Addressing Investment Governance and Board Oversight Issues
0
The information on this website is general in nature and does not take into account your objectives, financial situation, or needs. Consider seeking personal advice from a licensed adviser before acting on any information.
The Australian Prudential Regulation Authority (APRA) has recently imposed additional licence conditions on Fiducian Portfolio Services Limited (Fiducian) to address significant concerns regarding its investment governance frameworks and board effectiveness.
This action underscores APRA's commitment to ensuring robust oversight within the superannuation sector.
Fiducian, serving as the trustee for the Fiducian Superannuation Fund, manages approximately 9,779 member accounts with over $3.1 billion in funds under management. APRA's review identified several deficiencies in Fiducian's operations, including:
Inadequate investment selection criteria and insufficient due diligence for new investment options.
Ineffective monitoring and reporting frameworks for investment options, hindering the identification and response to performance and risk issues.
Poor management of potential conflicts of interest, especially concerning related-party service providers.
Deficiencies in board governance, notably in the quality of information provided and the effectiveness of board oversight.
To rectify these issues, APRA has mandated that Fiducian appoint an independent expert to conduct comprehensive reviews of its high-risk products and its investment governance and conflicts management frameworks. This proactive measure aims to enhance the protection of members' interests and ensure the fund's long-term sustainability.
For business owners and professionals, this development highlights the critical importance of robust governance and oversight in managing superannuation funds. Ensuring that your superannuation provider adheres to stringent regulatory standards is essential for safeguarding your financial future.
At Keyman Insurance Australia, we are dedicated to keeping you informed about significant industry developments that may impact your financial planning. Stay tuned for more updates and insights to help you navigate the evolving financial landscape.
Please Note: We do not endorse any specific products or companies. Some content is sourced from third parties, including press releases, and may not be independently verified for accuracy or completeness.
The Australian Prudential Regulation Authority (APRA) has recently imposed additional licence conditions on Fiducian Portfolio Services Limited (Fiducian) to address significant concerns regarding its investment governance frameworks and board effectiveness. This action underscores APRA's commitment to ensuring robust oversight within the superannuation sector. - read more
In a landmark move, the Australian Parliament has passed legislation prohibiting life insurers from using adverse genetic test results in their underwriting processes. This reform is set to take effect on 8 October 2026, marking a significant step towards eliminating genetic discrimination in the insurance industry. - read more
Zurich Financial Services Australia has announced its agreement to acquire ClearView Wealth for approximately A$415 million. This strategic acquisition is poised to enhance Zurich's footprint in the Australian life insurance sector, combining its robust capital foundation with ClearView's established product and advisory relationships. - read more
The Australian Prudential Regulation Authority (APRA) has recently refined its capital framework for longevity products, including annuities, aiming to foster innovation and enhance financial security for retirees. This move is part of APRA's ongoing efforts to create a supportive environment for the development of products that provide Australians with stable income streams during retirement. - read more
No comments yet. Be the first to share your thoughts.